Cargando…
Importance of antiresorptive therapies for patients with bone metastases from solid tumors
Patients with bone metastases are at risk of skeletal-related events such as pathologic fractures, spinal cord compression, the need for orthopedic surgery to bone, and palliative radiotherapy for severe bone pain. Antiresorptive therapies have demonstrated efficacy for reducing the risk of skeletal...
Autor principal: | Talreja, Draupadi B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459591/ https://www.ncbi.nlm.nih.gov/pubmed/23049278 http://dx.doi.org/10.2147/CMAR.S33983 |
Ejemplares similares
-
Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
por: Talreja, Draupadi B.
Publicado: (2012) -
Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer
por: Navarro‐Gonzalez, Elena
Publicado: (2022) -
Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration
por: Mjelstad, AnneMarthe, et al.
Publicado: (2019) -
New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015) -
Romosozumab and antiresorptive treatment: the importance of treatment sequence
por: Cosman, Felicia, et al.
Publicado: (2022)